Skip to main content

Table 1 Clinicopathological parameters of patients with CC in the training cohort and validation cohort

From: Identification and validation of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer

Clinical characteristic Total
(N = 273)
N (%)
Training cohort
(N = 193)
N (%)
Validation cohort
(N = 80)
N (%)
Age
 < 50 171 (62.6) 124 (64.2) 47 (58.8)
 > 50 102 (37.4) 69 (35.8) 33 (41.2)
Grade
 G1-G2 142 (52) 103 (53.4) 39 (48.8)
 G3-G4 105 (38.5) 72 (37.3) 33 (41.2)
 NA 26 (9.5) 18 (9.3) 8 (10)
T classification
 T1-T2 192 (70.3) 139 (72) 53 (66.3)
 T3-T4 26 (9.5) 17 (8.8) 9 (11.2)
 NA 55 (20.1) 37 (19.2) 18 (22.5)
N classification
 N0 118 (43.2) 92 (47.7) 26 (32.5)
 N1 53 (19.4) 32 (16.5) 21 (26.3)
 NA 102 (37.4) 69 (35.8) 33 (41.2)
M classification
 M0 101 (37) 69 (35.8) 32 (40)
 M1 10 (3.7) 8 (4.1) 2 (2.5)
 NA 162 (59.3) 116 (60.1) 46 (57.5)
AJCC stage
 I-II 209 (76.6) 150 (77.7) 59 (73.8)
 III-IV 58 (21.2) 38 (19.7) 20 (25)
 NA 6 (2.2) 5 (2.6) 1 (1.2)
  1. Abbreviations: T Tumor, N Node (regional lymph node), M Metastasis